. >> i think the sequence in written testimony later found n the tataris, and again this is a sort ofdvertisement for a regulatory reform resolution regime, because in september 2008 the government didn't really have the tools to resolve an institution of this size. the federal reserve could make a loan but you didn't really have the tools to put it to it quietly -- put it to bed quietly. >> a think it's critical fact thatou can't keep a clear answer to the question of-- and i understand why. it's not a criticism of you necessarily. but the fact that there is not a clear answer that can be articulate it across the administration's to why was it aig got unique treatment is a problem negative and. and i just -- it's an observation. i want to shift to something you said earlier in response to one of my collgue's questions. you said you had to think about the impact on other systemically significant firms during the period in september, 2008. but firms are you taing about? >> i did say that but i said it in the context of warren's estioning that we assure all of aig creditors for he bailo

. >> i think the sequence in written testimony later found in the tataris, and again this is a sort ofdvertisement for a regulatory reform resolution regime, because in september 2008 the government didn't really have the tools to resolve an institution of this size. the federal reserve could make a loan but you didn't really have the tools to put it to it quietl -- put it to bed quietly. >> a think it's critical fact that you can't keep a clear answer to the question of -- and i understand why. it's not a criticism of you necessarily. but the fact that there is not a clear answer that can be articulate it across the administration's to why was it aig got unique treatment is a problem negative and. and i just -- it's an observation. i want to shift to something you said earlier in response to one of my colleague's questions. you said you had to think about the impact on other systemically significant firms during the period in september, 2008. but firms are you talking about? >> i did say that but i said it in the context of warren's questioning that we assure all of aig creditors for

the cells is just kind of incomprehensible. >> when you produce this besides polio where else have they gone? >> everywhere. >> another example? and products? >> tataris -- you know, you can use them as a baseline. you can grow various things and if you want to grow a certain protein you can use the cells for that. and they -- research donner to go to the scientific data bases and you type in hela it's like going on google and typing and. the research on her cells -- it still goes today. >> what is hela? >> the name of the cells. >> henrietta -- >> it stands for henrietta lacks, right. i can't remember the number but it's like a number of scientific journal goals published each month using the hela cells is about, i can't remember exactly the around 3,000 papers a month. an enormous amount of research. >> how did you find this story? >> i first learned about the cells when i was 16 in a basic biology class. most people do. and -- >> after the 70's it became more public knowledge? >> well, no, most people don't know her name or anything about her that there are these cells so the scientists or biology teachers will talk about cancer and cells and say w